Axil Capital Partners
Overview
Axil Capital is a venture capital firm specializing in investments in the biomedical and healthcare technology sectors . It focuses on funding and supporting the growth of early-stage ventures, providing financial resources and strategic guidance . Axil invests across the full spectrum of the global biotech and healthcare space, ranging from seed to crossover stage venture capital opportunities . They diversify their investments across a wide range of technologies in the life science field, including biopharmaceuticals, platform technologies, medical devices, digital health and healthcare services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| LinqMed Inc. | Jan 2025 | Series B | Co-investor |
| Cellusion Inc. | Jun 2023 | Series C | Lead |
| LUCA Science | Aug 2020 | Series A | Lead |
| United Immunity, Co., Ltd. | Jun 2019 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Yoshitake Maeda
Venture Partner
Kimihito Usui
Senior Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Axil Capital Partners based?
Axil Capital Partners is headquartered in Tokyo, Tokyo, Japan.
When was Axil Capital Partners founded?
Axil Capital Partners was founded in 2017.
How many portfolio companies does Axil Capital Partners have?
Axil Capital Partners has 6 portfolio companies in Caplight's dataset.
What are some companies in Axil Capital Partners's portfolio?
Recent investments visible on Caplight include Fore Biotherapeutics, LinqMed Inc., Cellusion Inc., LUCA Science, United Immunity, Co., Ltd..
What was Axil Capital Partners's most recent investment?
Axil Capital Partners's most recent investment on Caplight was in Fore Biotherapeutics in 2026.
What sectors does Axil Capital Partners focus on?
Axil Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Axil Capital Partners focus on?
Axil Capital Partners typically invests at the Early stage.
What is Axil Capital Partners's AUM?
Axil Capital Partners's assets under management are estimated between $100.0M and $250.0M.